SSTR2 and pancreatic insulinoma: The detection rate of 111In-DTPA-octreotide scintigraphy is better for gastrointestinal NETs with sensitivity ranging from 80 to 100 % [28], but lower for insulinomas with sensitivity 20 to 60 % [26], as not all insulinomas express SSTR2 [29].